Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonists

NCT01737580 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Influenza Vaccination in Seniors

Interventions

DRUG: resiquimod
DRUG: placebo gel

Sponsor

University of British Columbia